Cardiovascular inflammation is reduced with methotrexate in diabetes
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cardiovascular inflammation is reduced with methotrexate in diabetes
Authors
Keywords
Diabetes, Inflammation, Methotrexate
Journal
MOLECULAR AND CELLULAR BIOCHEMISTRY
Volume 432, Issue 1-2, Pages 159-167
Publisher
Springer Nature
Online
2017-03-16
DOI
10.1007/s11010-017-3006-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2016 Russell Ross Memorial Lecture in Vascular Biology
- (2016) Ira Tabas ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The Cardiovascular Biology of Glucagon-like Peptide-1
- (2016) Daniel J. Drucker Cell Metabolism
- Multiple benefits of targeting inflammation in the treatment of type 2 diabetes
- (2016) Marc Y. Donath DIABETOLOGIA
- Treatment of diabetes and heart failure: joint forces
- (2016) Karl Swedberg et al. EUROPEAN HEART JOURNAL
- Sodium–glucose cotransporter 2 inhibition and cardiovascular risk reduction in patients with type 2 diabetes: the emerging role of natriuresis
- (2016) Harindra Rajasekeran et al. KIDNEY INTERNATIONAL
- Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants
- (2016) LANCET
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adipose Tissue Inflammation in the Pathogenesis of Type 2 Diabetes
- (2015) Ayano Kohlgruber et al. Current Diabetes Reports
- AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY – CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN – 2015 —EXECUTIVE SUMMARY
- (2015) Yehuda Handelsman et al. Endocrine Practice
- Follow-up of Glycemic Control and Cardiovascular Outcomes in Type 2 Diabetes
- (2015) Rodney A. Hayward et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
- (2014) Silvio E. Inzucchi et al. DIABETES CARE
- High-Intensity Statin Therapy Alters the Natural History of Diabetic Coronary Atherosclerosis: Insights From SATURN
- (2014) Brian Stegman et al. DIABETES CARE
- Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes
- (2014) Sophia Zoungas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rationale and design of the Cardiovascular Inflammation Reduction Trial: A test of the inflammatory hypothesis of atherothrombosis
- (2013) Brendan M. Everett et al. AMERICAN HEART JOURNAL
- Table of Contents
- (2013) Canadian Journal of Diabetes
- Molecular Mechanisms Linking Diabetes to the Accelerated Development of Atherosclerosis
- (2013) Melec G. Zeadin et al. Canadian Journal of Diabetes
- Risks and benefits of intensive blood pressure lowering in patients with type 2 diabetes
- (2013) D. M. Rabi et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Effects of disease modifying anti-rheumatic drugs on subclinical atherosclerosis and endothelial dysfunction which has been detected in early rheumatoid arthritis: 1-year follow-up study
- (2013) Aharna Guin et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Inflammation in Atherosclerosis
- (2012) Peter Libby ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Effects of methotrexate on inflammatory alterations induced by obesity: An in vivo and in vitro study
- (2012) Caroline Candida DeOliveira et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
- (2012) Jasvinder A. Singh et al. ARTHRITIS CARE & RESEARCH
- Systematic Review and Meta-Analysis of Methotrexate Use and Risk of Cardiovascular Disease
- (2011) Renata Micha et al. AMERICAN JOURNAL OF CARDIOLOGY
- Cardiometabolic Risk in Canada: A Detailed Analysis and Position Paper by the Cardiometabolic Risk Working Group
- (2011) Lawrence A. Leiter et al. CANADIAN JOURNAL OF CARDIOLOGY
- Endothelial Dysfunction in Diabetes: The role of reparatory mechanisms
- (2011) A. Avogaro et al. DIABETES CARE
- The immune system in atherosclerosis
- (2011) Göran K Hansson et al. NATURE IMMUNOLOGY
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
- (2010) The Emerging Risk Factors Collaboration LANCET
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review
- (2009) S. L. Westlake et al. RHEUMATOLOGY
- Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
- (2008) LANCET
- Effects of Intensive Glucose Lowering in Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
- (2008) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation